Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Heterogeneity of case definitions used in vaccine effectiveness studies--and its impact on meta-analysis.

Beyer WE.

Vaccine. 2006 Nov 10;24(44-46):6602-4. Epub 2006 Jun 8.

PMID:
16797799
[PubMed - indexed for MEDLINE]
2.

The effect of misclassification on evaluating the effectiveness of influenza vaccines.

Ozasa K.

Vaccine. 2008 Nov 25;26(50):6462-5. doi: 10.1016/j.vaccine.2008.06.039. Epub 2008 Jun 23. Review.

PMID:
18573297
[PubMed - indexed for MEDLINE]
3.

Essential tools for assessing influenza vaccine efficacy in improperly conducted studies: a Japanese perspective.

Hirota Y, Fukushima W, Fujieda M, Ohfuji S, Maeda A.

Vaccine. 2008 Nov 25;26(50):6455-8. doi: 10.1016/j.vaccine.2008.06.041. Epub 2008 Jun 23. Review.

PMID:
18573291
[PubMed - indexed for MEDLINE]
4.

Confounding in evaluating the effectiveness of influenza vaccine.

Mori M, Oura A, Ohnishi H, Washio M.

Vaccine. 2008 Nov 25;26(50):6459-61. doi: 10.1016/j.vaccine.2008.06.040. Epub 2008 Jun 23. Review.

PMID:
18573295
[PubMed - indexed for MEDLINE]
5.

New vaccine approaches for seasonal and pandemic influenza.

Palache B.

Vaccine. 2008 Nov 18;26(49):6232-6. doi: 10.1016/j.vaccine.2008.07.022. Epub 2008 Jul 30. Review.

PMID:
18674583
[PubMed - indexed for MEDLINE]
6.

Is influenza-like illness a useful concept and an appropriate test of influenza vaccine effectiveness?

Thomas RE.

Vaccine. 2014 Apr 17;32(19):2143-9. doi: 10.1016/j.vaccine.2014.02.059. Epub 2014 Feb 28. Review.

PMID:
24582634
[PubMed - indexed for MEDLINE]
7.

Efficacy of influenza vaccination in HIV-positive patients: a systematic review and meta-analysis.

Anema A, Mills E, Montaner J, Brownstein JS, Cooper C.

HIV Med. 2008 Jan;9(1):57-61. doi: 10.1111/j.1468-1293.2008.00515.x. Review.

PMID:
18199173
[PubMed - indexed for MEDLINE]
8.

Estimating influenza vaccine efficacy from challenge and community-based study data.

Basta NE, Halloran ME, Matrajt L, Longini IM Jr.

Am J Epidemiol. 2008 Dec 15;168(12):1343-52. doi: 10.1093/aje/kwn259. Epub 2008 Oct 29. Review.

PMID:
18974084
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Vaccine-preventable influenza disease burden from clinical trials of Vaxigrip - an inactivated split virion influenza vaccine - supports wider vaccine use.

Arnoux S, Weinberger C, Gessner BD.

Vaccine. 2007 Nov 7;25(45):7720-31. Epub 2007 Sep 20. Review.

PMID:
17920168
[PubMed - indexed for MEDLINE]
10.

Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Aug;7(6):713-9. doi: 10.1586/14760584.7.6.713. Review.

PMID:
18665769
[PubMed - indexed for MEDLINE]
11.

Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Hak E, Verheij TJ, Grobbee DE, Nichol KL, Hoes AW.

J Epidemiol Community Health. 2002 Dec;56(12):951-5. Review.

PMID:
12461118
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Physical interventions and injection techniques for reducing injection pain during routine childhood immunizations: systematic review of randomized controlled trials and quasi-randomized controlled trials.

Taddio A, Ilersich AL, Ipp M, Kikuta A, Shah V; HELPinKIDS Team.

Clin Ther. 2009;31 Suppl 2:S48-76. doi: 10.1016/j.clinthera.2009.07.024. Review.

PMID:
19781436
[PubMed - indexed for MEDLINE]
13.

Designing vaccines for pandemic influenza.

Horimoto T, Kawaoka Y.

Curr Top Microbiol Immunol. 2009;333:165-76. doi: 10.1007/978-3-540-92165-3_8. Review.

PMID:
19768405
[PubMed - indexed for MEDLINE]
14.

Influenza vaccine 2011-2012.

[No authors listed]

Med Lett Drugs Ther. 2011 Oct 17;53(1375):81-3. Review. No abstract available.

PMID:
21996921
[PubMed - indexed for MEDLINE]
15.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

PMID:
18547499
[PubMed - indexed for MEDLINE]
Free Article
16.

Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age group.

Newall AT, Kelly H, Harsley S, Scuffham PA.

Pharmacoeconomics. 2009;27(6):439-50. doi: 10.2165/00019053-200927060-00001. Review.

PMID:
19640008
[PubMed - indexed for MEDLINE]
17.

Influenza control in the 21st century: Optimizing protection of older adults.

Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, Puig-Barberà J, Schmitt J, Stephenson I.

Vaccine. 2009 Aug 13;27(37):5043-53. doi: 10.1016/j.vaccine.2009.06.032. Epub 2009 Jun 24. Review.

PMID:
19559118
[PubMed - indexed for MEDLINE]
18.

The use of inactivated influenza vaccine in children.

Wright PF.

Semin Pediatr Infect Dis. 2006 Oct;17(4):200-5. Review.

PMID:
17055371
[PubMed - indexed for MEDLINE]
19.

History of influenza vaccination programs in Japan.

Hirota Y, Kaji M.

Vaccine. 2008 Nov 25;26(50):6451-4. doi: 10.1016/j.vaccine.2008.06.042. Epub 2008 Jun 23. Review.

PMID:
18573292
[PubMed - indexed for MEDLINE]
20.

Pandemic H5N1 influenza vaccine development: an update.

El Sahly HM, Keitel WA.

Expert Rev Vaccines. 2008 Mar;7(2):241-7. doi: 10.1586/14760584.7.2.241. Review.

PMID:
18324892
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk